6640--NEW - Seahorse XF Pro Analyzer - Laboratory Instrumentation
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Department of Veterans Affairs, Network Contracting Office 17, intends to award a sole source Firm Fixed Price purchase order to Agilent Technologies, Inc. for the acquisition of one Agilent Seahorse XF Pro Analyzer, including associated software, consumables, and a five-year extended warranty, to support metabolic research at the VISN 17 Center of Excellence in Waco, Texas. The equipment is essential for real-time, simultaneous measurement of oxygen consumption rate and proton efflux rate in live cells, a capability uniquely provided by Agilent’s proprietary platform. The contract is being processed under FAR 13.106-1(b) due to the absence of commercially available alternatives, as no other vendor offers a functionally equivalent system with the required sensor technology, proprietary software integration, and exclusive service authorization. The acquisition is below the simplified acquisition threshold and is scheduled for immediate delivery as soon as possible. Agilent Technologies is the only source qualified to install, service, and train personnel on the system, with all components—including the Wave Pro Controller software, Seahorse Analytics platform, and compatibility with BioTek Cytation imaging systems—being proprietary and non-interchangeable. Market research confirmed no other manufacturer meets the technical specifications, and multiple federal agencies have previously recognized Agilent as the sole provider for similar instruments. While the notice invites potential offerors to submit capability statements by July 7, 2026, demonstrating full compliance with all technical requirements including 96-well microplate format, automated compound injection, and authorized service credentials, no competition is anticipated absent compelling evidence of equivalency. All responding sources must be active in SAM.gov, and failure to receive viable alternatives will result in award to Agilent Technologies, Inc.
General Info
Agency
NAICS
Place of Performance
TXSet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
SOLE SOURCE AUTHORITY AND JUSTIFICATION This acquisition is conducted under the authority of Federal Acquisition Regulation (FAR) 13.106-1(b), Soliciting from a Single Source. The estimated value of this acquisition is below the simplified acquisition threshold. The VA has determined that only Agilent Technologies, Inc. can meet the Government's requirements based on the following: 1. Unique Technology The Agilent Seahorse XF Pro Analyzer is the only commercially available platform capable of simultaneously measuring both oxygen consumption rate (OCR) and proton efflux rate (PER) in live cells in real time using a sealed microchamber and solid-state fluorophore sensor cartridge design. No other manufacturer produces a functionally equivalent system. 2. Proprietary Software and Consumables The requirement includes Wave Pro Controller software, Seahorse Analytics platform, and integration with Agilent BioTek Cytation imaging systems all proprietary components exclusive to the Agilent Seahorse ecosystem. These cannot be sourced from alternative vendors. 3. Authorized Service Restriction Per the Statement of Work, only licensed Agilent Technologies technicians are authorized to install, service, and provide training on this instrumentation. No other vendor is qualified or authorized to perform these functions. 4. Federal Procurement Precedent Multiple federal agencies including the National Institutes of Environmental Health Sciences (NIEHS), National Cancer Institute (NCI), U.S. Army DEVCOM-SC, and VA VISN 21 have each independently documented Agilent Technologies, Inc. as the sole source for Seahorse XF Analyzer platforms and confirmed that no commercially available equivalent exists. 5. Market Research Market research conducted by NCO 17 confirmed that no other vendor manufactures a live-cell metabolic analysis instrument meeting all technical specifications outlined in the Statement of Work dated June 2026. OPPORTUNITY FOR COMPETITION / RESPONSE INSTRUCTIONS This notice is not a request for competitive proposals or quotations. However, all responsible sources that believe they can satisfy this requirement in its entirety are encouraged to submit a written capability statement or quotation to the Contracting Officer no later than July 7, 2026, at 4:00 PM Central Time. Responses must be submitted in writing and must contain sufficient detail to allow the Government to determine whether the offeror can fully meet the technical requirements specified in the Statement of Work. Capability statements must address each technical specification, including simultaneous OCR/PER measurement, 96-well microplate format, automated compound injection, proprietary software integration, and authorized installation and service capability. Offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov at the time of response submission and at the time of any potential award. No telephone responses will be accepted. A determination by the Government not to compete this requirement based on responses to this notice is solely within the discretion of the Government. If no responsive capability statements or quotations are received by the response deadline, the VA intends to proceed with award to Agilent Technologies, Inc. POINT OF CONTACT Ognian D. Ivanov Contracting Officer Department of Veterans Affairs RPO West | NCO 17 | Lab Services Support (LSS) 5441 Babcock Rd., Suite 302, San Antonio, TX 78240 Email: ognian.ivanov@va.gov
NOTE: This notice is being posted in accordance with FAR 5.101 and FAR 13.106-1(b). The Government reserves the right to cancel this notice at any time.
